Skip to main content
Dermapharm Holding SE (ETR:DMP)
Germany flag Germany · Delayed Price · Currency is EUR
35.70
-0.25 (-0.70%)
Jun 11, 2025, 5:35 PM CET

Dermapharm Holding SE Revenue

Dermapharm Holding SE had revenue of 305.26M EUR in the quarter ending March 31, 2025, with 1.27% growth. This brings the company's revenue in the last twelve months to 1.20B, up 6.20% year-over-year. In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B with 3.89% growth.

Revenue (ttm)
1.20B
Revenue Growth
+6.20%
P/S Ratio
1.60
Revenue / Employee
332.22K
Employees
3,610
Market Cap
1.92B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.20B44.72M3.89%
Dec 31, 20231.15B110.19M10.59%
Dec 31, 20221.04B80.46M8.38%
Dec 31, 2021960.09M151.78M18.78%
Dec 31, 2020808.31M93.94M13.15%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 23.14B
Merck KGaA 21.32B
Bayer Aktiengesellschaft 46.58B
Fresenius SE & Co. KGaA 22.13B
Fresenius Medical Care AG 19.49B
Sartorius Aktiengesellschaft 3.44B
Carl Zeiss Meditec AG 2.17B
Fielmann Group AG 2.33B
Revenue Rankings

Dermapharm Holding SE News

More News